Amivantamab (Anti-HGFR / c-Met)
Amivantamab (Anti-HGFR / c-Met) is a human bispecific antibody targeting EGFR-MET.It has immune anticancer activity in non-small cell lung cancer (NSCLC). MW :146.1 KD.
| Trivial name | JNJ-61186372 |
| Catalog Number | A2601 |
| CAS# | 2171511-58-1 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/amivantamab-anti-hgfr-c-me-.html |